Low-grade fibromyxoid sarcoma: a clinicopathologic study of 18 cases, including histopathologic relationship with sclerosing epithelioid fibrosarcoma in a subset of cases

2011 ◽  
Vol 15 (5) ◽  
pp. 303-311 ◽  
Author(s):  
Bharat Rekhi ◽  
Mahesh Deshmukh ◽  
Nirmala A. Jambhekar
2020 ◽  
Vol 51 (3) ◽  
pp. 1025-1029
Author(s):  
Sage P Kramer ◽  
Christopher J Bowman ◽  
Zhen J Wang ◽  
Kathleen M Sheahon ◽  
Eric K Nakakura ◽  
...  

2018 ◽  
Vol 69 (3) ◽  
pp. 219-225 ◽  
Author(s):  
Andrea Sambri ◽  
Alberto Righi ◽  
Gianmarco Tuzzato ◽  
Davide Donati ◽  
Giuseppe Bianchi

Rare Sarcomas ◽  
2020 ◽  
pp. 129-143
Author(s):  
Thibaud Valentin ◽  
Sophie Le Guellec ◽  
Marie Pierre Castex ◽  
Christine Chevreau

2017 ◽  
Vol 12 (4) ◽  
pp. 619-622 ◽  
Author(s):  
Catherine Laliberte ◽  
Iona T. Leong ◽  
Howard Holmes ◽  
Eric A. Monteiro ◽  
Brian O’Sullivan ◽  
...  

2017 ◽  
Vol 25 (8) ◽  
pp. 702-704 ◽  
Author(s):  
Rana Asakra ◽  
Shane Zaidi ◽  
Khin Thway

Sclerosing epithelioid fibrosarcoma (SEF) is an aggressive neoplasm thought to be related to low-grade fibromyxoid sarcoma, which typically occurs in middle-aged adults in the deep soft tissues of the lower extremities and trunk. It comprises nests and cords of relatively uniform epithelioid polygonal cells with clear or eosinophilic cytoplasm in densely sclerotic stroma, and it is typically associated with EWSR1 gene rearrangements, and most commonly EWSR1-CREB3L1 fusions. As primary SEF can arise in bone, and bone is also a common metastatic site for SEF, its recognition at this site is important. We illustrate bone marrow showing diffuse infiltration by SEF and highlight the potential for confusion with a range of neoplasms such as carcinoma, hematolymphoid neoplasms, and other sarcomas.


2014 ◽  
Vol 54 (1) ◽  
pp. 28-38 ◽  
Author(s):  
Carlos Prieto-Granada ◽  
Lei Zhang ◽  
Hsiao-Wei Chen ◽  
Yun-Shao Sung ◽  
Narasimhan P Agaram ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document